Trial Profile
Comparative evaluation of immunogenicity and reactogenicity of bivalent oral poliovirus vaccine (bOPV) and trivalent oral poliovirus vaccine (tOPV) in the standard EPI schedule, with or without inactivated polio vaccine (IPV) administration at DTP3 contact: A randomized controlled trial - WHO EPI Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine live oral (Primary) ; Poliovirus vaccine inactivated
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Acronyms WHO EPI
- Sponsors Panacea Biotec
- 28 Apr 2014 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 05 Jul 2013 New trial record